Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort studyHiroyasu Ishikura, Takeshi Nishida, Mariko Mizunuma et al.|Critical Care|2017Cited by 52
Potential use of procalcitonin as biomarker for bacterial sepsis in patients with or without acute kidney injuryYoshihiko Nakamura, Hiroyasu Ishikura, Akira Murai et al.|Journal of Infection and Chemotherapy|2014Cited by 49
Endocan can be a predictive marker of severity of sepsis but cannot be a marker of acute respiratory distress syndrome in ICU patientsMariko Mizunuma, Akira Murai, Hiroyasu Ishikura et al.|Critical Care|2015Cited by 1
A case of nephrogenic diabetes insipidus which was successfully treated with high-dose indomethacinYasumasa Kawano, Hiroyasu Ishikura, Mariko Mizunuma et al.|Journal of the Japanese Society of Intensive Care Medicine|2016Cited by 0